Nature Research Round Table: Parkinson's Disease Therapy with Human Embryonic Stem Cells
Dr. Malin Parmar from Lund University talks about her work on cell-based therapies to treat Parkinson’s disease, as well as regulatory, safety, and efficacy requirements for the clinic. This presentation and the following Q&A session were moderated by Dr. Christine Mummery from the Leiden University Medical Center.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
Publish Date: November 01, 2019
Views: 78
Related Multimedia
-
Nature Research Round Table: hPSC Lines for Cell Therapies - Panel Discussion
Publish Date: November 01, 2019 Views: 80 -
Nature Research Round Table: Retinal Cell Therapy Using Human Embryonic Stem Cells
Publish Date: November 01, 2019 Views: 57 -
Nature Research Round Table: Human Pluripotent Stem Cell Lines as Disease Models
Publish Date: November 01, 2019 Views: 37
Explore Our Products
-
STEMdiff™ Midbrain Neuron Differentiation Kit
Differentiation kit for the generation of midbrain-patterned neuronal precursors from human ES and iPS cell-derived neural progenitor cells -
Animal component-free suspension culture medium for human ES and iPS cells -
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells -
STEMdiff™ Midbrain Neuron Maturation Kit
Maturation kit for generation of functional midbrain-type neurons from human ES and iPS cell-derived neuronal precursor cells
